X-5892930-T-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_181332.3(NLGN4X):​c.2338A>T​(p.Thr780Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 1 hem. )
Failed GnomAD Quality Control

Consequence

NLGN4X
NM_181332.3 missense

Scores

1
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.91

Publications

0 publications found
Variant links:
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
NLGN4X Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, X-linked 2
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17339182).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLGN4XNM_181332.3 linkc.2338A>T p.Thr780Ser missense_variant Exon 6 of 6 ENST00000381095.8 NP_851849.1 Q8N0W4-1A0A024RBV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLGN4XENST00000381095.8 linkc.2338A>T p.Thr780Ser missense_variant Exon 6 of 6 1 NM_181332.3 ENSP00000370485.3 Q8N0W4-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
183528
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
9.11e-7
AC:
1
AN:
1098270
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
1
AN XY:
363624
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
842150
Other (OTH)
AF:
0.00
AC:
0
AN:
46098
GnomAD4 genome
Cov.:
22
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2338A>T (p.T780S) alteration is located in exon 6 (coding exon 5) of the NLGN4X gene. This alteration results from a A to T substitution at nucleotide position 2338, causing the threonine (T) at amino acid position 780 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.34
T;T;T;.;T
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.91
.;D;.;D;.
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.17
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L;L;L;.;L
PhyloP100
6.9
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-2.0
N;.;N;.;N
REVEL
Benign
0.052
Sift
Benign
0.039
D;.;D;.;D
Sift4G
Benign
0.14
T;T;T;.;T
Polyphen
0.038
B;B;B;B;B
Vest4
0.35
MVP
0.37
MPC
0.90
ClinPred
0.40
T
GERP RS
3.8
Varity_R
0.27
gMVP
0.68
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758987323; hg19: chrX-5810971; API